303 related articles for article (PubMed ID: 8693713)
1. [Recombinant human erythropoietin in the treatment of anemia associated with lymphoproliferative diseases--chronic lymphadenosis and multiple myeloma].
Haber J; Spicka I; Petruzelka L; Kolesková E; Straub J; Jonásová A; Pospísilová B
Vnitr Lek; 1996 Apr; 42(4):262-7. PubMed ID: 8693713
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of treatment of anemia with erythropoietin in patients with multiple myeloma].
Adam Z; Krahulová M; Spelda S; Vorlícek J; Hejlová N; Hájek R; Tomíska M
Vnitr Lek; 1995 Nov; 41(11):767-72. PubMed ID: 8553596
[TBL] [Abstract][Full Text] [Related]
3. [Recombinant erythropoietin (r-HuEPO) in the treatment of anemia in multiple myeloma].
Spicka I; Haber J; Petruzelka L; Kolesková E; Sálková J; Straub J; Zounar R; Klener P
Cas Lek Cesk; 1996 Jul; 135(14):450-3. PubMed ID: 8925545
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the nutritional status during treatment of anemia using erythropoietin in patients on regular dialysis therapy].
Eiselt J; Veselá E; Racek J
Vnitr Lek; 1994 Jul; 40(7):437-9. PubMed ID: 8073661
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin and chronic lymphocytic leukemia.
Mauro FR; Gentile M; Foa R
Rev Clin Exp Hematol; 2002; Suppl 1():21-31. PubMed ID: 12735212
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia.
Ponchio L; Beguin Y; Farina G; Pedrazzoli P; Pedrotti C; Poggi G; Rosti V; Bergamaschi G; Battistel V; Cazzola M
Haematologica; 1992; 77(6):494-501. PubMed ID: 1289186
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Phair JP; Abels RI; McNeill MV; Sullivan DJ
Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin and the anemia of multiple myeloma.
Barlogie B; Beck T
Stem Cells; 1993 Mar; 11(2):88-94. PubMed ID: 8457789
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of erythropoietin in anemia of patients with immuno-lymphoproliferative disease].
Longo G; Fiorani C; Bonacorsi G; Vanzanelli P; Sani F; Bevini M; Curci G; Torelli U
Recenti Prog Med; 1992; 83(7-8):449-54. PubMed ID: 1529159
[TBL] [Abstract][Full Text] [Related]
11. [Tumor anemia. Overview of the role of human recombinant erythropoietin (r-hu-EPO) in treatment of tumor anemia].
Monnerat C; Leyvraz S
Praxis (Bern 1994); 1999 Jan; 88(5):178-88. PubMed ID: 10067375
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
Nowrousian MR
Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
[TBL] [Abstract][Full Text] [Related]
13. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS).
Marques da Costa R
Sangre (Barc); 1994 Apr; 39(2):105-10. PubMed ID: 8059287
[TBL] [Abstract][Full Text] [Related]
14. Treatment of the anemia of multiple myeloma: the role of recombinant human erythropoietin.
Barlogie B
Semin Hematol; 1993 Oct; 30(4 Suppl 6):25-7. PubMed ID: 8153675
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis].
Graf H; Mayer G; Cada EM; Thum J; Stummvoll HK
Wien Klin Wochenschr; 1987 Dec; 99(24):855-9. PubMed ID: 3439185
[TBL] [Abstract][Full Text] [Related]
16. Therapy of anemia in patients with multiple myeloma.
Adam Z; Krahulová M; Spelda S; Vorlícek J; Hejlová N; Hájek R; Tomíska M
Acta Med Austriaca; 1995; 22(4):59-64. PubMed ID: 8835422
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythropoietin for the treatment of chronic anemia in multiple myeloma and squamous cell carcinoma.
Ludwig H; Pecherstorfer M; Leitgeb C; Fritz E
Stem Cells; 1993 Sep; 11(5):348-55. PubMed ID: 8241947
[TBL] [Abstract][Full Text] [Related]
18. [Erythropoietin in the treatment of anemias].
Spicka I; Klener P; Lachmanová J; Háber J
Vnitr Lek; 1996 Mar; 42(3):197-9. PubMed ID: 8686210
[TBL] [Abstract][Full Text] [Related]
19. Interpatient variation in response to subcutaneous versus intravenous low dose erythropoietin.
Barclay PG; Fischer ER; Harris DC
Clin Nephrol; 1993 Nov; 40(5):277-80. PubMed ID: 8281716
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of recombinant human erythropoietin treatment of anaemia associated with multiple myeloma in haemodialysed patients.
Ruedin P; Pechère Bertschi A; Chapuis B; Benedet P; Leski M
Nephrol Dial Transplant; 1993; 8(4):315-8. PubMed ID: 8390005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
